Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.

The VMH AMPK-SNS-BAT axis may help treat cachexia and obesity.

Meis2 is essential for touch sensation and nerve function in mice.

The endocannabinoid system affects oil production and inflammation in skin cells.

The Skin POMC System affects hair growth and skin responses to stress.

Endocannabinoids help control mast cell activity in human skin.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Stress causes hair loss by disrupting hair growth cycles, and combining medical and cosmetic treatments can help manage it.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

The transcription factor Meis2 is essential for touch sensation and proper nerve development in touch receptors.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Neurosteroids help reduce seizures, but their withdrawal increases seizure activity.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.

Stress increases nerve growth factor, causing hair loss in mice.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Fat, bone, and the brain are interconnected in regulating energy and health.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Targeting Midkine can help reduce pain and itching in keloids.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Common gene patterns may cause skin autoimmune diseases.

Understanding molecular mediators can improve skin healing treatments.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

The availability of certain hormones and specific stimulation patterns affect long-term synaptic changes in the male rat brain.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.